<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//old.journalforclinicalstudies.com/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://old.journalforclinicalstudies.com/new-analysis-shows-high-rates-skin-clearance-measured-absolute-pasi-patients-moderate-severe-plaque-psoriasis-treated-janssens-tremfya-guselkumab/</loc>
		<lastmod>2017-12-06T10:54:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/gamamabs-pharma-sees-two-peer-reviewed-articles-published-oncotarget-detailing-anti-tumor-activity-gm1023c23k/</loc>
		<lastmod>2017-12-06T10:50:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/cluepoints-responds-sponsor-cro-demand-two-new-appointments/</loc>
		<lastmod>2017-12-06T10:45:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/adc-bio-signs-construction-agreement-sector-specialists-whp/</loc>
		<lastmod>2017-12-06T10:09:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/xultophy-reported-better-option-basal-bolus-insulin-therapy-manage-type-2-diabetes-participants-dual-vii-clinical-trial/</loc>
		<lastmod>2017-12-05T14:29:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/plasticell-anthony-nolan-partner-clinical-trials-ex-vivo-expanded-cord-blood-stem-cells/</loc>
		<lastmod>2017-12-05T11:52:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/regulations-recruitment-challenges-experiences-bulgaria/</loc>
		<lastmod>2017-12-04T15:07:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/updated-research-criteria-clinical-trials-across-alzheimers-disease-continuum/</loc>
		<lastmod>2017-12-04T14:48:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/bioclinica-appoints-david-herron-chief-executive-officer/</loc>
		<lastmod>2017-12-01T09:27:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/bioclinica-launches-clinical-adjudication-led-experienced-medical-specialists-researchers-enhanced-safety-efficacy-clinical-trials/</loc>
		<lastmod>2017-11-30T09:35:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/uk-trial-assessing-az-azd1775-head-neck-cancer/</loc>
		<lastmod>2017-11-29T11:10:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/viiv-trials-long-acting-two-drug-hiv-regimen/</loc>
		<lastmod>2017-11-29T11:05:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/az-teams-g1-lung-cancer-combination-therapy/</loc>
		<lastmod>2017-11-29T10:59:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/wirb-copernicus-group-partners-veeva-systems-inc-improve-speed-accuracy-institutional-review-board-irb-document-transfer/</loc>
		<lastmod>2017-11-29T10:10:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/bayernektar-experimental-inhaled-antibiotic-fails-phase-iii/</loc>
		<lastmod>2017-11-29T10:02:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/owlstone-medicals-breath-biopsy-platform-integrated-gsks-phase-ii-respiratory-disease-clinical-trial/</loc>
		<lastmod>2017-11-29T09:25:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/bevacizumab-leads-clinical-trial-activity-monoclonal-antibodies-says-globaldata/</loc>
		<lastmod>2017-11-29T09:18:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/cristal-therapeutics-awarded-e2-5-million-horizon-2020-grant-advance-cripec-docetaxel-phase-2-trials/</loc>
		<lastmod>2017-11-29T09:12:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/sotio-broadens-phase-ii-clinical-trial-program-ovarian-cancer/</loc>
		<lastmod>2017-11-29T09:07:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/ozanimod-superior-avonex-treating-relapsing-ms-phase-3-trials-celgene-reports/</loc>
		<lastmod>2017-11-22T13:30:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/tigenix-present-positive-52-week-phase-iii-cx601-data-eha-swg-scientific-meeting/</loc>
		<lastmod>2017-11-22T13:13:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/new-study-results-support-use-divitum-evaluation-pancreatic-cancer/</loc>
		<lastmod>2017-11-22T11:13:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/arcus-biosciences-secures-funding-advance-clinical-programs-ab928/</loc>
		<lastmod>2017-11-22T10:54:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/summit-completes-initial-dosing-trials-duchenne-muscular-dystrophy-drug/</loc>
		<lastmod>2017-11-22T10:31:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/results-randomized-double-blind-placebo-controlled-phase-iii-hercules-study-caplacizumab-patients-acquired-thrombotic-thrombocytopenic-purpura-presented-59th-annual/</loc>
		<lastmod>2017-11-22T10:24:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/khondrion-presents-phase-ii-khenergy-trial-data/</loc>
		<lastmod>2017-11-22T10:06:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/first-ever-effective-intervention-dementia-shown-large-study/</loc>
		<lastmod>2017-11-22T10:01:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/quanticate-launches-statistical-monitoring-services-following-ich-gcp-e6r2-addendum/</loc>
		<lastmod>2017-11-22T09:53:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/pci-clinical-services-announces-launch-mobile-app-comprehensive-customer-support-portal-webflow-enabling-efficient-clinical-supply-chain-management/</loc>
		<lastmod>2017-11-16T09:29:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/sages-brexanolone-meets-primary-endpoints-phase-3-postpartum-depression-trials/</loc>
		<lastmod>2017-11-15T10:54:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/novartis-breast-cancer-drug-kisqali-succeeds-phase-3-study-premenopausal-women/</loc>
		<lastmod>2017-11-15T10:50:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/redhill-biopharma-announces-last-patient-enrolled-phase-iii-study-rhb-104-crohns-disease/</loc>
		<lastmod>2017-11-15T10:33:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/clinical-placebo-study-confirms-medical-evidence-antinitus-patch-treatment-method-tinnitus/</loc>
		<lastmod>2017-11-15T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/quotient-sciences-launches-new-global-identity-quotient-clinical/</loc>
		<lastmod>2017-11-15T10:20:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/nanobiotix-presented-new-clinical-pre-clinical-data-confirming-nbtxr3s-significant-potential-role-immuno-oncology-sitc-annual-meeting/</loc>
		<lastmod>2017-11-15T10:15:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/cmed-demonstrate-encapsia-transforms-clinical-trial-data-management-capture-reporting-leading-oncology-meetings/</loc>
		<lastmod>2017-11-15T10:07:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/new-swedish-study-results-sabcs-show-divitum-blood-test-reduces-waiting-times-evaluating-breast-cancer-treatment/</loc>
		<lastmod>2017-11-15T10:02:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/crf-healths-trialmax-touch-selected-leading-specialty-pharmaceutical-company-pediatric-rare-disease-phase-ii-study/</loc>
		<lastmod>2017-11-15T09:53:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/imcyse-continues-patient-enrolment-phase-1b-trial-type-1-diabetes/</loc>
		<lastmod>2017-11-15T09:46:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/fortuna-fix-announces-series-b-financing-adding-amgen-ventures-macnguyen-family-office-shareholders/</loc>
		<lastmod>2017-11-08T13:54:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/bioclinica-acquires-cloud-based-image-management-technology/</loc>
		<lastmod>2017-11-08T13:18:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/amgen-novartis-expand-alzheimers-collaboration-new-trial/</loc>
		<lastmod>2017-11-08T11:25:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/industry-research-shows-97-companies-increase-use-real-world-patient-data-accurate-decision-making/</loc>
		<lastmod>2017-11-08T11:07:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/gsk-study-shows-copd-superiority-anoro-ellipta-versus-stiolto-respimat/</loc>
		<lastmod>2017-11-08T10:07:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/boehringer-says-cyltezo-humira-similar-efficacy-safety-people-ra/</loc>
		<lastmod>2017-11-08T09:57:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/trial-finds-blood-plasma-infusions-help-treat-alzheimers/</loc>
		<lastmod>2017-11-08T09:53:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/sotio-completes-enrolment-phase-iii-viable-study-late-stage-prostate-cancer/</loc>
		<lastmod>2017-11-08T09:46:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/new-phase-2-data-show-treatment-tremfya-guselkumab-improved-psoriatic-arthritis-symptoms-one-year/</loc>
		<lastmod>2017-11-07T16:06:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/stelara-ustekinumab-shows-positive-results-treatment-systemic-lupus-erythematosus-phase-2-trial/</loc>
		<lastmod>2017-11-07T15:56:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/sanofi-alnylam-present-positive-complete-results-apollo-phase-3-study-investigational-patisiran-hereditary-attr-hattr-amyloidosis-patients-polyneuropathy/</loc>
		<lastmod>2017-11-03T13:54:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/cluepoints-builds-late-phase-work-japan-launches-risk-based-monitoring-roadshow-tokyo/</loc>
		<lastmod>2017-11-03T13:38:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/almac-group-announces-acquisition-bioclin-laboratories/</loc>
		<lastmod>2017-11-01T13:20:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/ert-recognized-excellence-patient-centricity/</loc>
		<lastmod>2017-11-01T13:14:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/veeva-announces-partner-approach-best-class-randomization-trial-supply-management/</loc>
		<lastmod>2017-11-01T11:48:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/study-uses-genomics-make-treatment-recommendations-recurrent-glioblastoma-patients/</loc>
		<lastmod>2017-11-01T10:09:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/abbvies-psoriasis-drug-meets-co-primary-endpoints-three-phase-3-trials/</loc>
		<lastmod>2017-11-01T10:07:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/oncoquest-collaborate-tesaro-recurrent-ovarian-cancer-setting/</loc>
		<lastmod>2017-11-01T10:04:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/novartis-pediatric-multiple-sclerosis-drug-gilenya-shows-significant-effect-phase-iii-trial/</loc>
		<lastmod>2017-11-01T10:02:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/meta-analysis-using-real-world-data-evaluates-safety-profile-entyvio-vedolizumab-patients-moderate-severe-ulcerative-colitis-crohns-disease/</loc>
		<lastmod>2017-11-01T09:36:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/cristal-therapeutics-progresses-nanomedicine-cripec-docetaxel-phase-1b-development-patients-solid-tumours/</loc>
		<lastmod>2017-11-01T09:29:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/cmed-showcase-advanced-data-insights-analytics-capabilities-encapsia-clinical-data-suite-partnerships-clinical-trials-europe/</loc>
		<lastmod>2017-10-31T15:20:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/dupilumab-significantly-reduced-steroid-use-asthma-attacks-improved-lung-function-phase-3-study-people-severe-steroid-dependent-asthma/</loc>
		<lastmod>2017-10-31T15:12:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/new-data-show-symptom-improvement-within-one-week-patients-moderately-severely-active-crohns-disease-treated-stelara-ustekinumab/</loc>
		<lastmod>2017-10-31T15:08:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/vascular-dynamics-interim-data-mobiushd-presented-tct-conference-shows-significant-reductions-ambulatory-systolic-blood-pressure-six-months/</loc>
		<lastmod>2017-10-31T15:04:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/clinerion-expands-global-coverage-services-americas-adding-60-million-patients-north-america-via-partnership-provisio-inc/</loc>
		<lastmod>2017-10-31T15:01:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/icon-international-consortium-health-outcomes-measurement-unveil-worlds-first-global-patient-outcomes-benchmarking-platform/</loc>
		<lastmod>2017-10-31T11:08:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/crf-healths-trialmax-touch-solution-selected-landmark-global-oncology-study/</loc>
		<lastmod>2017-10-26T15:14:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/new-clinical-trials-monoclonal-antibodies-grown-115-last-ten-years-says-globaldata/</loc>
		<lastmod>2017-10-26T10:32:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/arran-chemical-company-completes-first-phase-three-part-strategic-plan-adapt-multimillion-euro-expansion-manufacturing-capacity-growth-next-generation-production-te/</loc>
		<lastmod>2017-10-25T13:21:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/ert-support-new-drug-development-exceeds-10000-studies/</loc>
		<lastmod>2017-10-25T12:23:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/cphi-worldwide-announces-winners-14th-pharma-awards/</loc>
		<lastmod>2017-10-25T10:43:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/biogen-extends-collaboration-eisai/</loc>
		<lastmod>2017-10-25T08:52:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/clinical-trials-advanced-development-innovative-drug-treatments-boosting-biotech-sector-gains/</loc>
		<lastmod>2017-10-25T08:40:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/global-blood-therapeutics-terminate-studies-idiopathic-pulmonary-fibrosis-program-pbr-staff-writer/</loc>
		<lastmod>2017-10-25T08:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/adc-therapeutics-raises-200m-advance-antibody-based-cancer-treatments/</loc>
		<lastmod>2017-10-25T08:10:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/celgene-stop-clinical-trials-crohns-disease-drug-ged-0301/</loc>
		<lastmod>2017-10-25T08:06:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/tenofovir-exalidex-safe-well-tolerated-early-hbv-trial/</loc>
		<lastmod>2017-10-24T13:35:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/almac-group-introduces-accountability-reconciliation-tracking-fully-configurable-extension-ixrs3-provides-end-end-traceability-imp/</loc>
		<lastmod>2017-10-24T13:28:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/neogenomics-announces-opening-first-international-laboratory-near-geneva-switzerland-support-clinical-trials/</loc>
		<lastmod>2017-10-24T13:26:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/pharma-publications-cphi-worldwide-2017/</loc>
		<lastmod>2017-10-24T10:20:17+00:00</lastmod>
		<image:image>
			<image:loc>https://old.journalforclinicalstudies.com/wp-content/uploads/2017/10/IMG-20171024-WA0000-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/aimmune-therapeutics-collaborate-sanofiregeneron/</loc>
		<lastmod>2017-10-20T10:05:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/singapore-conducts-research-asthma-copd/</loc>
		<lastmod>2017-10-20T10:01:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/nrg-isotope-can-help-predict-efficacy-chemo/</loc>
		<lastmod>2017-10-20T09:45:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/xbiotech-announces-first-patient-study-evaluating-mabp1-combination-onivyde-5-fluorouracilfolinic-acid-treatment-pancreatic-cancer/</loc>
		<lastmod>2017-10-18T15:23:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/ardelyxs-phase-3-study-tenapanor-ibs-c-meets-primary-endpoint/</loc>
		<lastmod>2017-10-18T14:01:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/aelix-therapeutics-appoints-dr-thomas-hecht-chairman-board-directors/</loc>
		<lastmod>2017-10-18T10:21:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/tocilizumab-yields-greater-efficacy-longer-drug-survival-tnfi/</loc>
		<lastmod>2017-10-18T09:29:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/miragen-therapeutics-reports-positive-clinical-data-mrg-106-patients-mycosis-fungoides-form-cutaneous-t-cell-lymphoma/</loc>
		<lastmod>2017-10-18T09:19:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/dimerix-appoints-medical-advisory-board-readiness-phase-2b-trials/</loc>
		<lastmod>2017-10-18T08:49:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/sgs-bavarian-nordic-develop-novel-differentiated-challenge-model-respiratory-syncytial-virus/</loc>
		<lastmod>2017-10-18T08:40:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/pfizers-lung-cancer-drug-lorlatinib-succeeds-phase-2-trial/</loc>
		<lastmod>2017-10-18T08:21:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/clinical-trials-news-exelixis-liver-cancer-drug-cabozantinib-meets-primary-end-point-phase-3-trial/</loc>
		<lastmod>2017-10-18T08:18:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/sanofi-regeneron-announce-positive-phase-2-study-results-dupilumab-patients-active-moderate-severe-eosinophilic-esophagitis/</loc>
		<lastmod>2017-10-17T10:57:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/clinerion-adds-fhir-data-model-set-standard-electronic-medical-record-formats/</loc>
		<lastmod>2017-10-17T10:56:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/ablynx-establishes-subsidiary-usa-appoints-general-manager/</loc>
		<lastmod>2017-10-17T10:54:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/antabio-raises-e-7-3m-series-financing-develop-novel-treatments-drug-resistant-gram-negative-infections/</loc>
		<lastmod>2017-10-16T09:48:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/editorial-calendar-2018/</loc>
		<lastmod>2017-10-13T08:26:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/mc2-therapeutics-announces-first-patient-dosed-pivotal-us-phase-3-trial-psoriasis-vulgaris/</loc>
		<lastmod>2017-10-11T13:45:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/motif-bios-iclaprim-meets-primary-endpoint-second-phase-3-abssi-trial/</loc>
		<lastmod>2017-10-11T12:41:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/bayer-janssen-halt-phase-iii-esus-study-anticoagulant-medicine-xarelto/</loc>
		<lastmod>2017-10-11T10:24:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/nanology-begins-nanopacs-phase-2-study-treat-ovarian-cancer/</loc>
		<lastmod>2017-10-11T10:21:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/shield-therapeutics-enrolls-patients-phase-3-study-ida-drug-feraccru/</loc>
		<lastmod>2017-10-11T10:18:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/anthem-healthcore-boehringer-initiate-pragmatic-clinical-trial-study-people-living-copd-real-world-setting/</loc>
		<lastmod>2017-10-11T10:16:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/study-ibalizumab-proves-promising-drug-resistant-hiv/</loc>
		<lastmod>2017-10-11T09:56:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/oncoarendi-therapeutics-begin-phase-1-clinical-evaluation-novel-class-medicines/</loc>
		<lastmod>2017-10-11T09:40:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/study-demonstrates-benefit-wests-id-adapter-improving-intradermal-administration-polio-vaccine/</loc>
		<lastmod>2017-10-11T09:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/appellate-court-orders-new-trial-vacates-permanent-injunction-ongoing-patent-case-regarding-praluentalirocumab/</loc>
		<lastmod>2017-10-06T08:51:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/breast-cancer-death-rate-drops-almost-40-percent-u-s/</loc>
		<lastmod>2017-10-06T08:33:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/researchers-rattled-revised-definition-clinical-trials/</loc>
		<lastmod>2017-10-06T08:27:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/dornier-medtech-opens-asia-pacific-headquarters-global-clinical-innovation-centre-singapore/</loc>
		<lastmod>2017-10-05T08:28:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/companies-increase-adoption-veeva-vault-ctms-streamline-clinical-processes-improve-visibility-across-studies/</loc>
		<lastmod>2017-10-04T10:34:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/fda-fast-track-designations-reach-20th-year/</loc>
		<lastmod>2017-10-04T10:16:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/amri-names-joseph-d-sangregorio-svp-chief-human-resources-officer/</loc>
		<lastmod>2017-10-04T09:57:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/new-artificial-skin-trials-offer-hope-acid-attack-victims/</loc>
		<lastmod>2017-10-04T09:28:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/amgen-cytomx-therapeutics-announce-strategic-collaboration-immuno-oncology/</loc>
		<lastmod>2017-10-04T09:09:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/immatics-receives-58-million-financing-develop-t-cell-receptor-based-immunotherapies/</loc>
		<lastmod>2017-10-04T08:57:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/chinese-researchers-use-traditional-ink-cancer-treatment/</loc>
		<lastmod>2017-10-04T08:44:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/korean-scientists-use-bilirubin-nanoparticles-cancer-therapy/</loc>
		<lastmod>2017-10-04T08:38:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/worldwide-clinical-trials-drug-sponsors-oct-southern-california-challenge-cros-detail-patient-recruitment-engagement-strategies/</loc>
		<lastmod>2017-09-27T13:46:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/hurricane-maria-shutters-much-puerto-ricos-pharma-manufacturing/</loc>
		<lastmod>2017-09-27T13:00:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/serum-institute-touts-phase-3-rotavirus-data-preps-first-deliveries/</loc>
		<lastmod>2017-09-27T10:45:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/set-challenging-glaxosmithklines-hepatitis-b-shot-dynavax-gears-heplisav-launch/</loc>
		<lastmod>2017-09-27T10:28:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/prostvac-flop-bavarian-nordic-showcases-6-month-rsv-data/</loc>
		<lastmod>2017-09-27T10:22:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/worldwide-clinical-trials-experts-explore-emerging-trends-cardiovascular-research-webinar-commemorating-world-heart-day/</loc>
		<lastmod>2017-09-27T09:50:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/sirion-biotech-vibalogics-partner-offer-complete-adeno-associated-virus-aav-services/</loc>
		<lastmod>2017-09-27T09:43:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/crf-health-augments-global-reach-official-opening-romania-office-appointment-new-vp-global-services/</loc>
		<lastmod>2017-09-26T08:29:11+00:00</lastmod>
		<image:image>
			<image:loc>https://old.journalforclinicalstudies.com/wp-content/uploads/2017/09/Adina-Tapalaga-Headshot-scaled.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/novartis-cosentyx-sets-new-benchmark-psoriasis-robust-5-year-sustained-phase-iii-efficacy-safety-data/</loc>
		<lastmod>2017-09-20T11:46:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/beta-blockers-not-needed-heart-attack-medications-taken/</loc>
		<lastmod>2017-09-20T11:34:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/cells-programmed-like-computers-fight-disease/</loc>
		<lastmod>2017-09-20T11:30:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/exciting-discovery-path-develop-new-type-vaccine-treat-global-viruses/</loc>
		<lastmod>2017-09-20T11:23:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/worldwide-clinical-trials-receives-finalist-nomination-2017-scrip-awards-second-year/</loc>
		<lastmod>2017-09-18T15:04:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/catalent-invests-5-5-million-increase-clinical-storage-capacity-philadelphia-site/</loc>
		<lastmod>2017-09-18T13:07:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/veeva-vault-etmf-helps-cancer-research-uk-improve-clinical-trial-efficiency-compliance-leading-charity-modernizes-trial-operations-develop-new-cancer-treatments-faster/</loc>
		<lastmod>2017-09-13T12:54:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/u-s-drugmakers-chop-fewer-jobs-year-despite-headwinds/</loc>
		<lastmod>2017-09-08T13:04:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/pfizer-puts-hemophilia-spin-ultrapopular-minecraft-educate-young-patients/</loc>
		<lastmod>2017-09-08T12:49:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/gates-foundation-commits-120m-nonprofit-paths-vaccine-work/</loc>
		<lastmod>2017-09-08T12:33:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/piramal-pharma-solutions-names-john-fowler-chief-operating-officer/</loc>
		<lastmod>2017-09-08T12:23:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/incoming-wave-biosimilars-oncology-special-session-esmo-2017/</loc>
		<lastmod>2017-09-07T15:44:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/mprove-health-greenphire-partner-deliver-first-kind-patient-engagement-solution/</loc>
		<lastmod>2017-09-06T15:52:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/sgs-clinical-research-strengthens-consultancy-service-accelerate-drugs-early-phase-development/</loc>
		<lastmod>2017-09-06T08:17:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/real-world-data-confirms-clinical-effectiveness-zebinix-eslicarbazepine-acetate-treatment-partial-onset-epilepsy-adults/</loc>
		<lastmod>2017-09-05T15:31:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/amal-therapeutics-raises-e8-million-chf-8-8-million-first-closing-series-b-financing-round/</loc>
		<lastmod>2017-09-05T10:29:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/multichannel-pipetting-make-smile/</loc>
		<lastmod>2017-09-04T15:32:51+00:00</lastmod>
		<image:image>
			<image:loc>https://old.journalforclinicalstudies.com/wp-content/uploads/2017/09/Multichannel-pipetting-1-scaled.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/updated-esmo-magnitude-clinical-benefit-scale-set-evaluate-single-arm-studies/</loc>
		<lastmod>2017-09-01T09:17:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/cmed-celebrates-one-year-anniversary-encapsia/</loc>
		<lastmod>2017-08-30T09:17:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/worldwide-clinical-trials-experts-advance-dialogue-future-clinical-research-immune-mediated-inflammatory-disorders/</loc>
		<lastmod>2017-08-24T13:27:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/clinerion-releases-revamped-design-improved-functionality-patient-recruitment-system/</loc>
		<lastmod>2017-08-24T12:47:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/given-chance-pay-less-patients-choose-cheaper-prescription-drugs/</loc>
		<lastmod>2017-08-24T12:40:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/alliance-foundation-trials-opens-global-trial-investigating-first-class-palbociclib-hr-her2-metastatic-breast-cancer/</loc>
		<lastmod>2017-08-24T12:37:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/extended-treatment-brilinta-reduces-risk-cardiovascular-death-29-patients-history-heart-attack/</loc>
		<lastmod>2017-08-24T12:34:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/reckitt-benckiser-rb-partner-health-hygiene-initiatives-zambia/</loc>
		<lastmod>2017-08-24T10:35:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/study-reveals-immature-cells-grow-red-blood-cells/</loc>
		<lastmod>2017-08-21T10:56:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/13th-annual-scrip-awards-2017-29-november-2017-hilton-park-lane-london/</loc>
		<lastmod>2017-08-21T10:55:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/gene-variant-activity-surprisingly-variable-tissues/</loc>
		<lastmod>2017-08-21T10:44:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/dimerix-ltd-dimerix-present-analysis-dmx-200-phase-2a-clinical-trial-chronic-kidney-disease-american-society-nephrology-asn-annual-kidney-week-2017/</loc>
		<lastmod>2017-08-16T12:37:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/cmed-demonstrate-capture-visualization-real-time-analysis-clinical-data-using-encapsia-mobile-clinical-trials-dpharm-2017/</loc>
		<lastmod>2017-08-16T08:54:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/pci-clinical-services-welcomes-marc-rees-international-clinical-sales-team/</loc>
		<lastmod>2017-08-16T08:30:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/clinerion-announces-new-technology-patient-identification-using-fully-anonymized-electronic-patient-data/</loc>
		<lastmod>2017-08-16T08:11:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/ferring-pharmaceuticals-scottish-medicines-consortium-approves-use-noqdirna-oral-lyophilisate-desmopressin-first-licensed-treatment-nocturia-due-idiopathic-nocturnal-polyur/</loc>
		<lastmod>2017-08-09T10:21:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/antidepressant-use-increases-risk-head-injuries-among-persons-alzheimers-disease/</loc>
		<lastmod>2017-08-09T10:12:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/wuxi-apptec-immunotherapy-report-biotech-sector-will-drive-biggest-advancements-decades-cancer-treatments/</loc>
		<lastmod>2017-08-09T10:10:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/clinical-trial-business-data-adopt-data-warehouse/</loc>
		<lastmod>2017-08-08T10:52:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/cphi-annual-reports-accurate-5-years/</loc>
		<lastmod>2017-07-27T13:22:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/treatment-cibd-now-easier-methotrexate-auto-injector-new-metoject-pen-approved-treatment-crohns-disease-europe/</loc>
		<lastmod>2017-07-26T13:02:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/cmc-biologics-enters-development-manufacturing-agreement-trellis-bioscience/</loc>
		<lastmod>2017-07-26T12:42:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/eisai-submits-marketing-authorisation-application-european-medicines-agency-lenvatinib-first-line-hepatocellular-carcinoma/</loc>
		<lastmod>2017-07-26T12:36:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/china-fda-us-fda-industry-leaders-debate-mah-pilot-adopted-nationwide/</loc>
		<lastmod>2017-07-21T08:10:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/avantor-opens-new-life-sciences-research-center/</loc>
		<lastmod>2017-07-19T13:02:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/new-thermo-scientific-samco-leakproof-vials-offer-enhanced-sample-user-safety/</loc>
		<lastmod>2017-07-19T12:58:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/clinerion-partners-cisiv-lead-innovation-real-world-research/</loc>
		<lastmod>2017-07-17T13:35:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/bioascent-appoints-new-ceo-announces-plans-expand-discovery-services-offering/</loc>
		<lastmod>2017-07-12T12:57:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/new-experimental-data-anti-inflammatory-effects-abx464-abivaxs-first-class-drug-candidate-achieve-functional-cure-hiv-patients-published-nature-scientific-reports/</loc>
		<lastmod>2017-07-12T12:44:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/biocartis-idyllatm-instrument-idyllatm-console-exempt-us-fda-510k-notification-requirements/</loc>
		<lastmod>2017-07-12T12:42:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/cphi-worldwide-opens-entries-largest-ever-pharma-awards/</loc>
		<lastmod>2017-07-10T13:51:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/onxeo-announces-positive-preclinical-proof-concept-results-confirming-asidna-activity-via-systemic-administration/</loc>
		<lastmod>2017-07-05T10:53:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/serialisation-improves-public-health/</loc>
		<lastmod>2017-07-05T10:49:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/zebinix-eslicarbazepine-acetate-data-demonstrate-no-significant-negative-consequences-neurocognitive-function-children-focal-epilepsy/</loc>
		<lastmod>2017-06-28T13:30:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/genkyotex-initiates-patient-enrollment-phase-2-trial-gkt831-primary-biliary-cholangitis/</loc>
		<lastmod>2017-06-28T13:23:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/widecells-group-plc-cellplan-revenue-launch-first-uk-insurance-product-stem-cell-treatment/</loc>
		<lastmod>2017-06-27T13:29:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/mobile-health-mhealth-increasingly-popular-shift-towards-value-based-medicine-continues-says-gbi-research/</loc>
		<lastmod>2017-06-22T08:13:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/mdxhealth-queensland-university-technology-collaborate-oral-cancer-liquid-biopsy-test/</loc>
		<lastmod>2017-06-21T12:18:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/quotient-ortho-clinical-diagnostics-present-symposium-role-extended-phenotyping-blood-matching-isbt/</loc>
		<lastmod>2017-06-21T12:15:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/tresiba-demonstrated-no-increased-risk-major-cardiovascular-events-significant-reduction-rates-severe-hypoglycaemia-compared-insulin-glargine-u100-devote-trial/</loc>
		<lastmod>2017-06-13T13:48:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/liver-cancer-space-invigorated-promising-pipeline-says-gbi-research/</loc>
		<lastmod>2017-06-13T13:47:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/mrc-technology-biocartis-initiate-development-liquid-biopsy-test-breast-cancer/</loc>
		<lastmod>2017-06-07T08:42:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/peli-biothermal-exhibits-award-winning-solutions-cts-nordics/</loc>
		<lastmod>2017-06-07T08:39:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/international-pharma-regulatory-summit-27th-28th-july-2017-singapore/</loc>
		<lastmod>2017-05-31T09:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/west-present-biologics-trends-innopack-pharma-confex/</loc>
		<lastmod>2017-05-31T08:43:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/mprove-health-achieves-record-12-month-revenue-growth-adds-25-life-science-clients/</loc>
		<lastmod>2017-05-25T09:11:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/european-commission-grants-marketing-authorisation-zebinix-eslicarbazepine-acetate-daily-monotherapy-adults-newly-diagnosed-partial-onset-epilepsy/</loc>
		<lastmod>2017-05-24T08:34:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/widecells-group-widecells-company-attendance-british-dental-conference-exhibition/</loc>
		<lastmod>2017-05-24T08:27:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/pci-clinical-services-announces-move-phase-european-clinical-site-expansion/</loc>
		<lastmod>2017-05-16T13:41:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/global-japanese-pharmaceutical-firm-selects-icardiac-oncology-clinical-trial/</loc>
		<lastmod>2017-05-16T13:38:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/clintec-secures-queens-award-enterprise-international-trade-category-second-time/</loc>
		<lastmod>2017-05-09T12:36:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/recipharm-opens-new-gmp-suite-clinical-trial-material/</loc>
		<lastmod>2017-05-02T12:55:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/metrion-biosciences-appoints-chief-operating-officer-head-business-development/</loc>
		<lastmod>2017-05-02T12:52:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/cphi-expert-calls-anda-approvals-reduced-two-thirds-order-lower-drug-costs/</loc>
		<lastmod>2017-04-26T14:07:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/live-cphi-japan-2017-japanese-pharma-companies-predict-17-growth-2017/</loc>
		<lastmod>2017-04-26T14:04:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/connect-aptar-pharma-rdd-europe-2017-april-25-28-antibes-france/</loc>
		<lastmod>2017-04-25T08:59:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://old.journalforclinicalstudies.com/greens/</loc>
		<lastmod>2017-04-24T10:00:42+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Rank Math SEO Plugin (c) Rank Math - rankmath.com -->